Editorial Board
Laura Orsolini
Psychopharmacology Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK · United Kingdom
Editorial leadership for Journal of Child and Adolescent Psychiatry ISSN 2643-6655
Research interests
- Addiction
- Drug Abuse
- Drug Misuse
- Eating Disorders
- Food Addiction
- Novel Psychoactive Substances
- Alcohol Use Disorders
- Addictions In Child
- Adolescent Psychiatry
Biography
- MD, Psychiatrist, MSc Crim, senior research assistant at Psychopharmacology Drug MISUSE and NPS research unit, University of Hertfordshire, Hatfield, UK
- Dr Laura Orsolini is a physician (graduated at the University of Pavia, Department of Public Health, Experimental and Forensic Medicine – Division of Forensic Sciences, in 2009) and a researcher interested in Novel Psychoactive Substances (NPS), Addiction, Clinical Psychopharmacology, Forensic Psychiatry and Criminology.
- She is also a Psychiatry Resident at the Academic Department of Experimental and Clinical Medicine, Division of Psychiatry. Polytechnic University of Marche, Italy and research fellow in the drug misuse and psychopharmacology research group, coordinated by Professor Fabrizio Schifano, at the University of Hertfordshire, School of Life and Medical Sciences in Hatfield, UK.
- Under the supervision of Professor Fabrizio Schifano, she collaborated to the EU-funded ‘S.O.N. project’, coordinated by the Italian Department for Anti-drug Policies (DPA), for the promotion and dissemination of a Family Internet Security software application, regarding the access to drug selling websites.
- She is also active member of the EFPT (European Federation of Psychiatric Trainees) working group on Psychoactive Substance Use Disorders.
- Her main research topics include the study of the most recent NPS and legal highs, the deep web, the e-Psychonauts, the online drug marketplaces and the cyber-communities related to NPS.
Selected publications
- Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors 2018 cited 155×
- C-Reactive Protein as a Biomarker for Major Depressive Disorder? 2022 cited 147×
- Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review 2019 cited 107×
- Serotonin reuptake inhibitors and breastfeeding: a systematic review 2015 cited 90×
- A Systematic Review on TeleMental Health in Youth Mental Health: Focus on Anxiety, Depression and Obsessive-Compulsive Disorder 2021 cited 79×
- Emotional Dysregulation in Adolescents: Implications for the Development of Severe Psychiatric Disorders, Substance Abuse, and Suicidal Ideation and Behaviors 2020 cited 65×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCAP for your work?
This journal is guided by Laura Orsolini (Psychopharmacology Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.